← Open Payments lookup

KULSOOM JUNAID: Open Payments

NPI 1497827968 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,601 in 59 payments from 9 companies in 2025. Trend: 2023 $1,003 · 2024 $919 · 2025 $2,601

Food & beverage: $1,419Travel & lodging: $1,182
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.13$1,655
Teva Pharmaceuticals USA, Inc.17$240
E.R. Squibb & Sons, L.L.C.7$190
Otsuka America Pharmaceutical, Inc.6$188
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$119
Alkermes, Inc.5$102
Vanda Pharmaceuticals Inc.2$52
ACADIA Pharmaceuticals Inc2$37
Janssen Pharmaceuticals, Inc1$19

Products named: COBENFY, INGREZZA, UZEDY, REXULTI, CAPLYTA, AUSTEDO XR, ARISTADA, ABILIFY MAINTENA.

Industry payments across MO — which companies pay providers there.